Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial
Titel:
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial
Auteur:
Feagan, Brian G Sands, Bruce E Siegel, Corey A Dubinsky, Marla C Longman, Randy S Sabino, João Laurent, Olivier Luo, Allison Lu, Jiandong Nguyen, Deanna D Muñoz-Elias, Ernesto J Llewellyn, Heather Wang, Yong Jang, InSock Bilsborough, Janine Marchelletta, Ron Towfic, Fadi Yen, Mark Anderson, Jaclyn K DuVall, Aaron Kierkus, Jaroslaw Woynarowski, Marek Al Kharrat, Houssam Targan, Stephan R McGovern, Dermot P B